Core Viewpoint - Kintor Pharmaceutical Co., Ltd. (科济药业-B) shares rose over 4%, currently trading at 18.3 HKD with a transaction volume of 12.33 million HKD, following the announcement of an updated share buyback plan [1] Group 1: Share Buyback Plan - The company announced an updated share buyback plan, effective from November 13, 2025, allowing the repurchase of up to 25.461 million shares within 50 trading days in the open market [1] - The updated buyback plan's 25.461 million shares, combined with shares repurchased in 2025, will represent 5% of the total issued shares as of the authorization date in 2025 [1] Group 2: Shareholding Changes - The board was informed that Yijie Biotechnology Holdings Limited and its concert parties (collectively referred to as "Yijie Concert Group") purchased a total of 100,000 shares between November 6 and November 10, 2025 [1] - Following this acquisition, the Yijie Concert Group holds 218 million shares, accounting for approximately 37.92% of the total issued shares as of the announcement date, excluding treasury shares [1]
科济药业-B涨超4% 公司购回股份及主要股东增持股份